TL;DR
The current state of GRPR-targeted theranostics from bench to bedside is explored, highlighting the preclinical development of various GRPR-targeting compounds and clinical applications and providing a quo vadis GRPR.
AI-generated by Semantic Scholar
Authors
Clément Morgat, Heying Duan, Simone Dalm, Elif Hindié, Thomas Günther, Bernd J. Krause, Vasko Kramer, Florine Cavelier, Andrew W. Stephens, Stephen Moran, Laura Lamb, Andrei Iagaru
